The current financial score of Biodesix Inc is 7.41. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 26.86M, representing a year-over-year increase of 34.18%, while its net profit experienced a year-over-year increase of 36.58%.
The current valuation score of Biodesix Inc is 8.92. Its current P/E ratio is -6.24, which is -99.19% below the recent high of -0.05 and -23.79% above the recent low of -7.72.
The current earnings forecast score of Biodesix Inc is 8.29. The average price target is 39.00, with a high of 41.00 and a low of 35.00.
The current price momentum score of Biodesix Inc is 5.42. Currently, the stock price is trading between the resistance level at 29.78 and the support level at 19.89, making it suitable for range-bound swing trading.
The current institutional shareholding score of Biodesix Inc is 3.00. The latest institutional shareholding proportion is 29.99%, representing a quarter-over-quarter decrease of 17.90%.
The current risk assessment score of Biodesix Inc is 4.12. The company's beta value is 0.55. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.